Inventors:
Burt A. Adelman - Cambridge MA, US
Assignee:
ELEVEN BIOTHERAPEUTICS, INC. - Cambridge MA
International Classification:
A61K 39/395, A61K 38/17, A61K 38/10, A61K 38/08, A61K 31/56, A61K 31/7105
US Classification:
4241351, 4241581, 514 44 A, 514 208, 4241721, 128887
Abstract:
Disclosed herein are methods for administering an IL-1 or IL-17 antagonist for treating ocular surface disorders, e.g., a dry eye disorder. The antagonists can be administered topically using an opthalmic composition.